Klassista tietoa EBV viruksesta ja B-soluista

. 2012 Jan;91(1):65-9.

doi: 10.1016/j.ejcb.2011.01.014. Epub 2011 Mar 29.

Human B cells on their route to latent infection--early but transient expression of lytic genes of Epstein-Barr virus

Markus Kalla  ¹ , Wolfgang Hammerschmidt

Affiliations

• PMID: 21450364
• DOI: 10.1016/j.ejcb.2011.01.014

Abstract

Epstein-Barr virus (EBV) is a human tumor virus and a paradigm of herpesviral latency. Mature naïve or memory B cells are EBV's preferred targets in vitro and in vivo. Upon infection of any B cell with EBV, the virus induces cellular proliferation to yield lymphoblastoid cell lines (LCLs) in vitro and establishes a latent infection in them. In these cells a 'classical' subset of latent viral genes is expressed that orchestrate and regulate cellular activation and proliferation, prevent apoptosis, and maintain viral latency. Surprisingly, little is known about the early events in primary human B cells infected with EBV. Recent analyses have revealed the initial but transient expression of additional viral genes that do not belong to the 'classical' latent subset. Some of these viral genes have been known to initiate the lytic, productive phase of EBV but virus synthesis does not take place early after infection. The early but transient expression of certain viral lytic genes is essential for or contributes to the initial survival and cell cycle entry of resting B cells to foster their proliferation and sustain a latent infection. This review summarizes the recent findings and discusses the presumed function(s) of viral genes expressed shortly but transiently after infection of B-lymphocytes with EBV.

Copyright © 2011 Elsevier GmbH. All rights reserved.

Similar articles

• Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.

  Niller HH, Wolf H, Minarovits J. Autoimmunity. 2008 May;41(4):298-328. doi: 10.1080/08916930802024772. PMID: 18432410 Review.  Epstein-Barr virus (EBV) is a human herpesvirus hiding in a latent form in memory B cells in the majority of the world population. Although, primary EBV infection is asymptomatic or causes a self-limiting disease, infectious mononucleosis, the virus is associated with a wide variety of neoplasms developing in immunosuppressed or immunodeficient individuals, but also in patients with an apparently intact immune system.
• The lytic phase of epstein-barr virus requires a viral genome with 5-methylcytosine residues in CpG sites.

  Kalla M, Göbel C, Hammerschmidt W. J Virol. 2012 Jan;86(1):447-58. doi: 10.1128/JVI.06314-11. Epub 2011 Oct 26. PMID: 22031942 Free PMC article.Our data suggest that unmethylated virion DNA is part of EBV's strategy to prevent the viral lytic phase in newly infected B cells, allowing it to establish its characteristic latent infection in them
• First Days in the Life of Naive Human B Lymphocytes Infected with Epstein-Barr Virus.

  Pich D, Mrozek-Gorska P, Bouvet M, Sugimoto A, Akidil E, Grundhoff A, Hamperl S, Ling PD, Hammerschmidt W. mBio. 2019 Sep 17;10(5):e01723-19. doi: 10.1128/mBio.01723-19. PMID: 31530670 Free PMC article..IMPORTANCE The preferred target of Epstein-Barr virus (EBV) is human resting B lymphocytes. We found that their infection induces a well-coordinated, time-driven program that starts with a substantial increase in cell volume, followed by cellular DNA synthesis after 3 days and subsequent rapid rounds of cell divisions on the next day accompanied by some DNA replication stress (DRS). Two to 3 days later, the cells decelerate and turn into stably proliferating lymphoblast cell lines. With the aid of 16 different recombinant EBV strains, we investigated the individual contributions of EBV's multiple latent genes during early B-cell infection and found that many do not exert a detectable phenotype or contribute little to EBV's prelatent phase. The exception is EBNA2 that is essential in governing all aspects of B-cell reprogramming. EBV relies on EBNA2 to turn the infected B lymphocytes into proliferating lymphoblasts preparing the infected host cell for the ensuing stable, latent phase of viral infection. In the early steps of B-cell reprogramming, viral latent genes other than EBNA2 are dispensable, but some, EBNA-LP, for example, support the viral program and presumably stabilize the infected cells once viral latency is established.
• Immunodominance of lytic cycle antigens in Epstein-Barr virus-specific CD4+ T cell preparations for therapy.

  Adhikary D, Behrends U, Boerschmann H, Pfünder A, Burdach S, Moosmann A, Witter K, Bornkamm GW, Mautner J. PLoS One. 2007 Jul 4;2(7):e583. doi: 10.1371/journal.pone.0000583. PMID: 17611619 Free PMC article. Review.
• Patterns of Epstein-Barr virus latent and replicative gene expression in Epstein-Barr virus B cell lymphoproliferative disorders after organ transplantation.

  Rea D, Fourcade C, Leblond V, Rowe M, Joab I, Edelman L, Bitker MO, Gandjbakhch I, Suberbielle C, Farcet JP, et al. Transplantation. 1994 Aug 15;58(3):317-24. PMID: 8053055